Drug Information

Drug General Information
Drug ID
D0ME8Z
Former ID
DNC008106
Drug Name
5-(2-fluorobenzyloxy)quinazoline-2,4-diamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529261]
Formula
C15H13FN4O
Canonical SMILES
C1=CC=C(C(=C1)COC2=CC=CC3=C2C(=NC(=N3)N)N)F
InChI
1S/C15H13FN4O/c16-10-5-2-1-4-9(10)8-21-12-7-3-6-11-13(12)14(17)20-15(18)19-11/h1-7H,8H2,(H4,17,18,19,20)
InChIKey
SFJOSBAEWKPKPY-UHFFFAOYSA-N
PubChem Compound ID
24778025
Target and Pathway
Target(s) Dihydrofolate reductase Target Info Inhibitor [529261]
PathWhiz Pathway Folate Metabolism
Pterine Biosynthesis
Reactome E2F mediated regulation of DNA replication
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
Metabolism of folate and pterines
G1/S-Specific Transcription
References
Ref 529261J Med Chem. 2008 Feb 14;51(3):449-69. Epub 2008 Jan 19.Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Ref 529261J Med Chem. 2008 Feb 14;51(3):449-69. Epub 2008 Jan 19.Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.